US Patent Issued to Newave Pharmaceutical on May 26 for "Inhibitor of BTK and mutants thereof" (California Inventor)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,467, issued on May 26, was assigned to Newave Pharmaceutical Inc. (Pleasanton, Calif.).

"Inhibitor of BTK and mutants thereof" was invented by Yi Chen (Pleasanton, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure includes compounds of Formula (I) (1) wherein Q0, Q1, Q2, Q3, Q4, Z, W, i, j, m, n, Warhead, R0, R1, R3, R4, R5, R6, and R7, are defined herein. Also disclosed is a method for treating a neoplastic disease, autoimmune disease, and inflammatory disorder with these compounds."

The patent was filed on Feb. 24, 2020, under Application No. 17/431,460.

*For further information, including images, charts and tables, please visi...